Effects of atorvastatin on renal function in patients with dyslipidemia and chronic kidney disease: assessment of clinical usefulness in CKD patients with atorvastatin (ASUCA) trial

BACKGROUND: Dyslipidemia is a risk factor for the progression of chronic kidney disease (CKD). While conventional lipid lowering therapy provides a benefit to CKD management, the effect of statins on eGFR remains unclear. METHODS: A prospective, multi-center, open-labeled, randomized trial. Total of...

Descripción completa

Detalles Bibliográficos
Autores principales: Kimura, Genjiro, Kasahara, Masato, Ueshima, Kenji, Tanaka, Sachiko, Yasuno, Shinji, Fujimoto, Akira, Sato, Toshiya, Imamoto, Miyuki, Kosugi, Shinji, Nakao, Kazuwa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Japan 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5486454/
https://www.ncbi.nlm.nih.gov/pubmed/27392909
http://dx.doi.org/10.1007/s10157-016-1304-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5486454/
https://www.ncbi.nlm.nih.gov/pubmed/27392909
http://dx.doi.org/10.1007/s10157-016-1304-6

Ejemplares similares